HLUYY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 05:30):

Stats
आज की मात्रा	7 539.00
औसत मात्रा	1 786.00
बाजार मूल्य	0.00
Last Dividend	$0.204 ( 2022-03-24 )
Next Dividend	$0 ( N/A )
P/E	28.95
ATR14	$2.36 (10.72%)

H. Lundbeck A/S सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

H. Lundbeck A/S वित्तीय

Annual	2021
राजस्व:	$16.30B
सकल लाभ:	$12.65B (77.62 %)
EPS:	$0

FY	2021
राजस्व:	$16.30B
सकल लाभ:	$12.65B (77.62 %)
EPS:	$0

FY	2020
राजस्व:	$17.67B
सकल लाभ:	$13.50B (76.42 %)
EPS:	$7.95

FY	2019
राजस्व:	$17.36B
सकल लाभ:	$13.97B (80.50 %)
EPS:	$13.42

Financial Reports:

No articles found.

H. Lundbeck A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

H. Lundbeck A/S Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.350	2013-03-22
Last Dividend	$0.204	2022-03-24
Next Dividend	$0	N/A
Payout Date	2022-04-05
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	$4.94	--
Avg. Dividend % Per Year	0.00%	--
Score	0.28	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-14)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.28

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PPWLM	Ex Dividend Junior	2023-07-19	Quarterly	0.00%
EDNMY	Ex Dividend Junior	2023-06-05	Annually	0.00%
UOVEY	Ex Dividend Knight	2023-08-04	Annually	0.00%
KGFHY	Ex Dividend Knight	2023-10-12	Annually	0.00%
BURCA	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
SATLF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
FIZN	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
YAHOF	Ex Dividend Junior	2024-03-28	Annually	0.00%
MCRAA	Ex Dividend Knight	2023-09-20	Quarterly	0.00%
CLZNY	Ex Dividend Knight	2023-06-09	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0	1.500	-1.111	-1.667	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.977	0.800	-0.117	-0.0934	[1 - 3]
quickRatioTTM	0.258	0.800	-3.19	-2.55	[0.8 - 2.5]
cashRatioTTM	0.258	1.500	9.68	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	13.14	1.000	6.25	6.25	[3 - 30]
operatingCashFlowPerShareTTM	3.08	2.00	8.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.776	1.000	0.397	0.397	[0.2 - 0.8]
operatingProfitMarginTTM	0.123	1.000	9.53	9.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	0	2.50	-0.714	-1.667	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.08	2.00	8.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0375	1.000	-1.561	0	[0.1 - 0.5]
Total Score				0.155

H. Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.